- Advertisement -

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected in South Africa in November 2021. The World Health Organization...

2021 Federal Budget backs biotech – Mirage News

Announcements in the 2021 Federal...

Unusual partners aid blood vessel growth

AUGUSTA, Ga. (March 8, 2022) – Insufficient oxygen to an area like the heart or legs, called hypoxia, is a cue to our bodies to...

On the Lookout: Prometheus Veterans Launch Mirador Therapeutics With $400 Million

After being bought out by Merck in June 2023 for nearly $11 billion, some of the ex-brass from Prometheus Biosciences headed to a spear-shaped...

NIH funding supports research on first therapeutic drug to regenerate heart...

Reviewed by Emily Henderson, B.Sc.May 29 2020 With funding from the National Institutes of Health, University of Arkansas researchers hope to develop the first therapeutic...

Low-risk differentiated thyroid cancer patients in the U. S. experience lower...

A new study has shown that overall and cause-specific mortality rates in individuals in the U.S. with low-risk differentiated thyroid cancer (DTC) are low....

Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity,...

Small molecules continue to play a major part in pharmaceutical development, but increasing molecular complexity, accelerated timelines, and evolving manufacturing and regulatory requirements are...

From Models to Agents: The Next Phase of AI Adoption in...

In recent years, the artificial intelligence (AI) conversation has been dominated by increasingly capable large language models. Every few months, models improve on mathematical...

Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and...

Small molecules continue to play a major part in pharmaceutical development, but increasing molecular complexity, accelerated timelines, and evolving manufacturing and regulatory requirements are...

From Models to Agents: The Next Phase of AI Adoption in Molecular Discovery

In recent years, the artificial intelligence (AI) conversation has been dominated by increasingly capable large language models. Every few months, models improve on mathematical...

DeepCyte Launches Single-Cell Metabolomic Reference Atlas of Drug Toxicity Mechanisms

DeepCyte launched the DeeTox Atlas, a single-cell metabolomic reference atlas of drug toxicity mechanisms. Enterprise pilot programs with global pharmaceutical companies are expected to...

more new items

Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity,...

Small molecules continue to play a major part in pharmaceutical development, but increasing molecular complexity, accelerated timelines, and evolving manufacturing and regulatory requirements are...

From Models to Agents: The Next Phase of AI Adoption in...

In recent years, the artificial intelligence (AI) conversation has been dominated by increasingly capable large language models. Every few months, models improve on mathematical...

DeepCyte Launches Single-Cell Metabolomic Reference Atlas of Drug Toxicity Mechanisms

DeepCyte launched the DeeTox Atlas, a single-cell metabolomic reference atlas of drug toxicity mechanisms. Enterprise pilot programs with global pharmaceutical companies are expected to...